NCT02434263 - A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve | Biotech Hunter

Enrollment

165

Participants

Timeline

Start Date

August 13, 2015

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2025

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

Hydra TAVI

Percutaneous Replacement of the Diseased Aortic Valve

Trial Locations (6)

King Chulalongkorn Hospital, Bangkok

General Hospital of Athens Ippokration, Athens

Prince of Wales Hospital, Hong Kong

Vilnius University Hospital Santariškiu Klinikos, Vilnius

Waikato Hospital, Hamilton

Instytut Kardiologii im.Prymasa, Warsaw